Nevertheless, the effect of NGF on patients with ischaemic stroke during convalescence is not satisfactory as the molecular weight of NGF is approximately 13.4 kDa, which makes it difficult for it to cross the Blood-Brain Barrier (BBB) under normal conditions and affects its ability to reach the effective drug concentration to exert therapeutic effect.6 Here, NGF is linked to ischemic stroke.